WASHINGTON, D.C.– The U.S. National Security Commission on Emerging Biotechnology issued its first report since its creation through the National Defense Authorization Act of FY2022. The bipartisan ...

America can either cede the future of biotechnology to our adversaries or summon the vision and resolve to lead it.

The National Security Commission on Emerging Biotechnology (NSCEB) delivered its major report and action plan to Congress in early April with a blunt message: the world is entering a new age driven by ...

Samsung is proceeding with an investment in Averr BioTechnology (Averr Bio), a U.S.-based biotech company specializing in ...

DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

A White House statement says, “The Participants intend to collaborate closely on developing pro-innovation AI policy frameworks, promoting the export of trusted AI technology stacks, developing ...

RENO, Nev., Oct. 10, 2025 (GLOBE NEWSWIRE) -- AI Technology Group Inc. (OTCID: AIPG) (the “Company”) announced that it has filed an amended Form 10 with the Securities and Exchange Commission and ...

The biotechnology market is anticipated to expand at a rapid pace owing to high incidence of chronic diseases, growing demand for novel treatments, and advancements in cell technologies. Surge in ...

Sana's first-in-human study shows HIP technology allows islet cells to avoid immune rejection and produce insulin without immunosuppression. Reliance on initial results: The press release heavily ...

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

Biotechnology is revolutionizing industries and transforming human health worldwide. Today’s biotech leaders must bridge laboratory breakthroughs with business strategy to bring life-changing ...

Quornix, a biotechnology startup from Bloomington, Indiana, won the 2025 grand prize for developing pioneering therapeutic technologies to treat bacterial diseases.